Related Experiment Videos
(Unlearned) lessons from John Graunt and Kenneth Rothman: a "CLASSic" example
Felix M Arellano1, Jordi Castellsague,
1Drug Safety Surveillance, Pfizer Inc, Peapack, New Jersey 07977, USA. felix.m.arellano@pfizer.com
Clinical Therapeutics
|December 25, 2003
Summary
Statistical significance alone is insufficient for causal inference. Prespecifying study endpoints is crucial for reliable scientific conclusions, avoiding oversimplification in research.
Area of Science:
- Epidemiology
- Biostatistics
- Medical Research Methodology
Background:
- Historical contributions of John Graunt and Kenneth J. Rothman to statistical reasoning.
- The prevalent reliance on statistical significance in interpreting study results.
- The critical need for predefined study endpoints in research.
Purpose of the Study:
- To review the foundational work on statistical significance and prespecification.
- To critique the overreliance on statistical significance for causal inference.
- To advocate for a more rational approach to interpreting research findings.
Main Methods:
- Commentary synthesizing historical and contemporary perspectives.
- Analysis of the dangers of substituting statistical significance for causal inference.
- Illustrative example using the Celecoxib Long-term Arthritis Safety Study.
Main Results:
- Statistical significance is a flawed sole criterion for evaluating study outcomes.
- Prespecification of study endpoints is essential for robust causal inference.
- The Celecoxib Long-term Arthritis Safety Study exemplifies the pitfalls of post-hoc analysis.
Conclusions:
- Researchers must move beyond a simplistic reliance on statistical significance.
- Adopting prespecified endpoints enhances the validity of causal inference.
- A rational approach to causal inference is paramount in scientific research.